Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2003 1
2006 5
2007 1
2008 4
2009 2
2010 1
2011 2
2012 3
2013 1
2014 1
2015 2
2016 4
2017 4
2018 4
2019 5
2020 7
2021 10
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

54 results
Results by year
Filters applied: . Clear all
Page 1
Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia.
von Stackelberg A, Locatelli F, Zugmaier G, Handgretinger R, Trippett TM, Rizzari C, Bader P, O'Brien MM, Brethon B, Bhojwani D, Schlegel PG, Borkhardt A, Rheingold SR, Cooper TM, Zwaan CM, Barnette P, Messina C, Michel G, DuBois SG, Hu K, Zhu M, Whitlock JA, Gore L. von Stackelberg A, et al. Among authors: brethon b. J Clin Oncol. 2016 Dec 20;34(36):4381-4389. doi: 10.1200/JCO.2016.67.3301. Epub 2016 Oct 31. J Clin Oncol. 2016. PMID: 27998223 Clinical Trial.
Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study.
Locatelli F, Zugmaier G, Mergen N, Bader P, Jeha S, Schlegel PG, Bourquin JP, Handgretinger R, Brethon B, Rossig C, Chen-Santel C. Locatelli F, et al. Among authors: brethon b. Blood Cancer J. 2020 Jul 24;10(7):77. doi: 10.1038/s41408-020-00342-x. Blood Cancer J. 2020. PMID: 32709851 Free PMC article. No abstract available.
A phase 1 study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study).
Brivio E, Locatelli F, Lopez-Yurda M, Malone A, Díaz-de-Heredia C, Bielorai B, Rossig C, van der Velden VHJ, Ammerlaan ACJ, Thano A, van der Sluis IM, den Boer ML, Chen Y, Sleight B, Brethon B, Nysom K, Sramkova L, Øra I, Vinti L, Chen-Santel C, Zwaan CM. Brivio E, et al. Among authors: brethon b. Blood. 2021 Mar 25;137(12):1582-1590. doi: 10.1182/blood.2020007848. Blood. 2021. PMID: 33067614 Free PMC article. Clinical Trial.
Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study.
Pieters R, De Lorenzo P, Ancliffe P, Aversa LA, Brethon B, Biondi A, Campbell M, Escherich G, Ferster A, Gardner RA, Kotecha RS, Lausen B, Li CK, Locatelli F, Attarbaschi A, Peters C, Rubnitz JE, Silverman LB, Stary J, Szczepanski T, Vora A, Schrappe M, Valsecchi MG. Pieters R, et al. Among authors: brethon b. J Clin Oncol. 2019 Sep 1;37(25):2246-2256. doi: 10.1200/JCO.19.00261. Epub 2019 Jul 8. J Clin Oncol. 2019. PMID: 31283407 Clinical Trial.
Blinatumomab in pediatric relapsed/refractory B-cell acute lymphoblastic leukemia: RIALTO expanded access study final analysis.
Locatelli F, Zugmaier G, Mergen N, Bader P, Jeha S, Schlegel PG, Bourquin JP, Handgretinger R, Brethon B, Rössig C, Kormany WN, Viswagnachar P, Chen-Santel C. Locatelli F, et al. Among authors: brethon b. Blood Adv. 2022 Feb 8;6(3):1004-1014. doi: 10.1182/bloodadvances.2021005579. Blood Adv. 2022. PMID: 34979020 Free PMC article.
[Infant acute leukemia].
Brethon B, Cavé H, Fahd M, Baruchel A. Brethon B, et al. Bull Cancer. 2016 Mar;103(3):299-311. doi: 10.1016/j.bulcan.2015.11.009. Epub 2016 Jan 27. Bull Cancer. 2016. PMID: 26826739 French.
Varicella post-exposure management for pediatric oncology patients.
Costa G, Orbach D, Saulpic J, Sarda-Thibault H, Hanslik T, Brethon B, Tabone MD, Raimbault S, Papillard S, Guillaumat C, Nathanson S, Pellegrino B, Belloy M, Mesples B, Trioche P, Jaber H, Raimondo G, Gilet C, Cohen-Gogo S. Costa G, et al. Among authors: brethon b. Bull Cancer. 2022 Mar;109(3):287-295. doi: 10.1016/j.bulcan.2021.11.016. Epub 2022 Jan 31. Bull Cancer. 2022. PMID: 35093244
COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE).
Rouger-Gaudichon J, Bertrand Y, Boissel N, Brethon B, Ducassou S, Gandemer V, Halfon-Domenech C, Leblanc T, Leverger G, Michel G, Petit A, Ray-Lunven AF, Rohrlich PS, Schneider P, Sirvent N, Strullu M, Baruchel A; Leukemia Committee of the SFCE. Rouger-Gaudichon J, et al. Among authors: brethon b. Bull Cancer. 2021 May;108(5):490-500. doi: 10.1016/j.bulcan.2021.02.004. Epub 2021 Mar 11. Bull Cancer. 2021. PMID: 33781551 Free PMC article. Review.
Impact of COVID-19 on cancer care: A survey from the French Society of Pediatric Oncology (SFCE).
Rouger-Gaudichon J, Gariazzo L, Thébault E, Brethon B, Fenwarth L, Gambart M, Alimi A, Réguerre Y, Piguet C, Jubert C, Gouache E, Thébaud E, Plantaz D, Paillard C, Raimbault S, Haouy S, Schneider P, Phulpin A, Mallebranche C, Dubrasquet M, de Berranger E, Devoldere C, Laithier V, Poirée M, Thouvenin S, Carausu L, Dupraz C, Bouttefroy S, André N, Gandemer V. Rouger-Gaudichon J, et al. Among authors: brethon b. Pediatr Blood Cancer. 2021 Jan;68(1):e28554. doi: 10.1002/pbc.28554. Epub 2020 Sep 7. Pediatr Blood Cancer. 2021. PMID: 32893961 No abstract available.
Invasive Fungal Infections in Immunocompromised Children: Novel Insight Following a National Study.
Olivier-Gougenheim L, Rama N, Dupont D, Saultier P, Leverger G, AbouChahla W, Paillard C, Gandemer V, Theron A, Freycon C, Pluchart C, Blouin P, Pellier I, Thouvenin-Doulet S, Desplantes C, Ducassou S, Oudot C, Rouger-Gaudichon J, Cheikh N, Poiree M, Schneider P, Plat G, Contet A, Rialland F, Gouache E, Brethon B, Bertrand Y, Domenech C. Olivier-Gougenheim L, et al. Among authors: brethon b. J Pediatr. 2021 Sep;236:204-210. doi: 10.1016/j.jpeds.2021.05.016. Epub 2021 May 13. J Pediatr. 2021. PMID: 33991540
54 results